These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7306917)

  • 21. Cloacogenic tumors of the anorectal junction.
    Meijer S; Hoitsma HF; Koster RH; van Kordelaar JJ
    Neth J Surg; 1982 Mar; 34(1):21-6. PubMed ID: 7078782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized prospective trial comparing 5-fluorouracil (NSC-19893) to 5-fluorouracil and methyl-CCNU (NSC-95441) in advanced gastrointestinal cancer.
    Baker LH; Vaitkevicius VK; Gehan E
    Cancer Treat Rep; 1976 Jun; 60(6):733-7. PubMed ID: 954013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic cloacogenic carcinoma of the anus: sequential responses to adriamycin and cis-dichlorodiammineplatinum(II).
    Fisher WB; Herbst KD; Sims JE; Critchfield CF
    Cancer Treat Rep; 1978 Jan; 62(1):91-7. PubMed ID: 627000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients.
    Samson MK; Baker LH; Fraile RJ; Izbicki RM; Vaitkevicius VK
    Cancer Treat Rep; 1977; 61(1):59-64. PubMed ID: 67895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iv methyl-CCNU and ftorafur with or without methanol-extracted residue of BCG for metastatic adenocarcinoma of the colon.
    Diggs CH; Wiernik PH; Smyth AC
    Cancer Treat Rep; 1977 Nov; 61(8):1581-3. PubMed ID: 336200
    [No Abstract]   [Full Text] [Related]  

  • 26. Combined actions of 5-fluorouracil and 1-(2-chloroethyl)-3-(4-methylcyclohexyl)-1-nitrosourea on human colonic carcinoma cells in vitro.
    Sutton JE; Roos IA; Hillcoat BL
    Cancer Res; 1982 Dec; 42(12):5172-5. PubMed ID: 7139620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
    Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
    Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cutaneous metastasis of a cloacogenic tumor].
    Peppe H; Bianchi C; Bianchi O; Stringa S
    Med Cutan Ibero Lat Am; 1987; 15(4):293-7. PubMed ID: 3320623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of small cell carcinoma of the lung using methyl-CCNU (NSC-95441) combined with cyclophosphamide (NSC-26271) and vincristine (NSC-67574) in a 3-week schedule.
    Taylor SG; Donavan MA; Sponzo RW; Cunningham TJ; Horton J
    Cancer Chemother Rep; 1975; 59(6):1127-30. PubMed ID: 769951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The West Midlands gastric carcinoma chemotherapy trial: planning and results.
    Kingston RD; Ellis DJ; Powell J; Brookes VS; Waterhouse JA; Hurst MD; Smith JA
    Clin Oncol; 1978 Mar; 4(1):55-69. PubMed ID: 346275
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cloacogenic carcinoma].
    Stejskalová A; Bednár B
    Cesk Patol; 1989 May; 25(2):99-103. PubMed ID: 2743450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
    Kemeny N; Yagoda A; Braun D
    Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapy for squamous carcinoma of the cervix: doxorubicin--methyl CCNU.
    Day TG; Wharton JT; Gottlieb JA; Rutledge FN
    Am J Obstet Gynecol; 1978 Nov; 132(5):545-8. PubMed ID: 717454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of ftorafur with mitomycin C versus ftorafur with methyl-CCNU in untreated colorectal cancer.
    Buroker T; Wojtaszak B; Dindogru A; DeMattia M; Baker L; Groth C; Vaitkevicius VK
    Cancer Treat Rep; 1978 May; 62(5):689-92. PubMed ID: 350398
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phase II study of methyl-CCNU in the treatment of advanced pancreatic carcinoma.
    Moertel CG; Douglass HO; Hanley J; Carbone PP
    Cancer Treat Rep; 1976 Nov; 60(11):1659-61. PubMed ID: 1035508
    [No Abstract]   [Full Text] [Related]  

  • 36. Lack of effectiveness of combined 5- fluorouracil and methyl-CCNU therapy in advanced colorectal cancer.
    Lokich JJ; Skarin AT; Mayer RJ; Frei E
    Cancer; 1977 Dec; 40(6):2792-6. PubMed ID: 589555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nitrosourea combinations in lung cancer.
    Livingston RB
    Cancer Treat Rep; 1976 Jun; 60(6):757-760. PubMed ID: 182365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methyl-CCNU for patients with previously treated metastatic neuroblastoma--a phase II study.
    Evans AE; Bernstein I; Finklestein J; Klemperer M; Leikin S; Weiner JM; Hammond GD
    Cancer Treat Rep; 1977; 61(1):83-5. PubMed ID: 324623
    [No Abstract]   [Full Text] [Related]  

  • 39. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs. methyl-CCNU plus bolus weekly 5-FU. A Southwest Oncology Group study.
    Baker LH; Talley RW; Matter R; Lehane DE; Ruffner BW; Jones SE; Morrison FS; Stephens RL; Gehan EA; Vaitkevicius VK
    Cancer; 1976 Jul; 38(1):1-7. PubMed ID: 779949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methyl-CCNU and methotrexate therapy in patients with advanced colorectal cancer after failure of 5-fluorouracil chemotherapy.
    Zorzitto ML; Myers R; Bazos MJ; Shepherd FA; Evans WK
    Am J Clin Oncol; 1986 Feb; 9(1):27-30. PubMed ID: 3953490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.